(Q55244180)

28 June 2018

http://europepmc.org/abstract/MED/2425014

title

Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. (English)

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

author

Françoise Barré-Sinoussi

2

object named as

Barré-Sinoussi F

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

author name string

Yamamoto JK

1

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

Bolton V

3

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

Pedersen NC

4

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

Gardner MB

5

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

publication date

1 April 1986

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

published in

Journal of Interferon Research

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

volume

6

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

issue

2

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

page(s)

143-152

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

cites work

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.6189183

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Production of high-titered interferon in cultures of human diploid cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

The glomerular permeability determined by dextran clearance using Sephadex gel filtration

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Influence of interferon on virus-particle synthesis in oncornavirus-carrier lines. II. Evidence for a direct effect on particle release

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Human leukocyte interferon produced by E. coli is biologically active

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Large-scale induction and production of human and mouse immune interferons

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Interferon-directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Large Scale Production and Properties of Human Leukocyte Interferon Used in Clinical Trials

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Severe acquired immune deficiency syndrome in male homosexuals: diminished capacity to make interferon-alpha in vitro associated with severe opportunistic infections

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Trapping of oncornavirus particles at the surface of interferon-treated cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Interferons in the treatment of human cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Factors Influencing Production of Interferon by Human Lymphoblastoid Cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Interferon inhibits C-type virus at a posttranscriptional, prerelease step

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Characterization of the RNA dependent DNA polymerase of a new human T lymphotropic retrovirus (lymphadenopathy associated virus)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

Persistence of the Viral Genome in Interferon-Treated Cells Infected with Oncogenic or Nononcogenic Viruses

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/JIR.1986.6.143

A microplaque reduction assay for human and mouse interferon

1 reference

18 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1139/M75-186

Identifiers

DOI

10.1089/JIR.1986.6.143

1 reference

28 June 2018

http://europepmc.org/abstract/MED/2425014

1 reference

28 June 2018